These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 29535235)
1. Patient-Centered Guidelines for Geriatric Diabetes Care: Potential Missed Opportunities to Avoid Harm. McCreedy EM; Kane RL; Gollust SE; Shippee ND; Clark KD J Am Board Fam Med; 2018; 31(2):192-200. PubMed ID: 29535235 [TBL] [Abstract][Full Text] [Related]
2. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults. Tasci I; Safer U; Naharci I; Sonmez A Prim Care Diabetes; 2018 Apr; 12(2):192-194. PubMed ID: 29396204 [TBL] [Abstract][Full Text] [Related]
3. A National Survey of Physicians' Views on the Importance and Implementation of Deintensifying Diabetes Medications. Pilla SJ; Jalalzai R; Tang O; Schoenborn NL; Boyd CM; Bancks MP; Mathioudakis NN; Maruthur NM J Gen Intern Med; 2024 May; 39(6):992-1001. PubMed ID: 37940754 [TBL] [Abstract][Full Text] [Related]
4. Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets. Migdal A; Abrahamson M; Peters A; Vint N Ann Med; 2018 Sep; 50(6):453-460. PubMed ID: 30103624 [TBL] [Abstract][Full Text] [Related]
5. Intensive glycemic control in younger and older U.S. adults with type 2 diabetes. Casagrande S; Cowie CC; Fradkin JE J Diabetes Complications; 2017 Aug; 31(8):1299-1304. PubMed ID: 28571934 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment. Mata-Cases M; Franch-Nadal J; Real J; Gratacòs M; López-Simarro F; Khunti K; Mauricio D Diabetes Obes Metab; 2018 Jan; 20(1):103-112. PubMed ID: 28656746 [TBL] [Abstract][Full Text] [Related]
7. Physician perspectives on de-intensifying diabetes medications. Genere N; Sargis RM; Masi CM; Nathan AG; Quinn MT; Huang ES; Laiteerapong N Medicine (Baltimore); 2016 Nov; 95(46):e5388. PubMed ID: 27861373 [TBL] [Abstract][Full Text] [Related]
8. A retrospective cross-sectional study of type 2 diabetes overtreatment in patients admitted to the geriatric ward. Wojszel ZB; Kasiukiewicz A BMC Geriatr; 2019 Sep; 19(1):242. PubMed ID: 31477024 [TBL] [Abstract][Full Text] [Related]
9. American College of Physicians diabetes guidelines attempt to turn back the clock, conflating good HbA1c with hypoglycemia. Bloomgarden Z; Einhorn D; Handelsman Y; Misra A; Zonszein J; Grunberger G; Jellinger PS; Garber AJ J Diabetes; 2018 Aug; 10(8):618-620. PubMed ID: 29655268 [No Abstract] [Full Text] [Related]
10. Patterns and trends in insulin intensification among patients with type 2 diabetes: a systematic review. Polinski JM; Connolly JG; Curtis BH; Seeger JD; Gaskins K; Perez M; Smith BF; Shrank WH Prim Care Diabetes; 2014 Jul; 8(2):101-9. PubMed ID: 24275103 [TBL] [Abstract][Full Text] [Related]
11. [Management of hyperglycaemia in type 2 diabetes: a patient-centered approach]. Scheen AJ; Mathieu C Rev Med Liege; 2012 Dec; 67(12):623-31. PubMed ID: 23342872 [TBL] [Abstract][Full Text] [Related]
12. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit. Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750 [TBL] [Abstract][Full Text] [Related]
13. Liberating A1C goals in older adults may not protect against the risk of hypoglycemia. Munshi MN; Slyne C; Segal AR; Saul N; Lyons C; Weinger K J Diabetes Complications; 2017 Jul; 31(7):1197-1199. PubMed ID: 28343792 [TBL] [Abstract][Full Text] [Related]
14. Management and treatment goals in Polish patients with type 2 diabetes of short duration: results of the ARETAEUS2-Grupa study. Bała MM; Płaczkiewicz-Jankowska E; Leśniak W; Topór-Mądry R; Michałejko M; Jankowski M; Strzeszyński L; Sieradzki J; Czupryniak L; Pol Arch Med Wewn; 2013; 123(11):573-81. PubMed ID: 24241157 [TBL] [Abstract][Full Text] [Related]
15. Treatment patterns among older patients with type 2 diabetes in the United States: a retrospective cohort study. Fu H; Curtis BH; Schuster DP; Festa A; Kendall DM Diabetes Technol Ther; 2014 Dec; 16(12):833-9. PubMed ID: 25068375 [TBL] [Abstract][Full Text] [Related]
16. Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes: Population-Based Modeling Study, 2011-2014. Mahoney GK; Henk HJ; McCoy RG Mayo Clin Proc; 2019 Sep; 94(9):1731-1742. PubMed ID: 31422897 [TBL] [Abstract][Full Text] [Related]
17. Guidelines ease up on glycemic control for some patients with type 2 diabetes. Mitka M JAMA; 2012 Jun; 307(21):2243-4. PubMed ID: 22706812 [No Abstract] [Full Text] [Related]
18. Criteria influencing the choice of starting insulin regimen in patients with type 2 diabetes in routine clinical practice: baseline data from the Algerian cohort of the A₁chieve study. Malek R; Arbouche Z; Bachaoui M; Zinai S; Dahaoui A; Senoussaoui S; Salah-Mansour A Diabetes Res Clin Pract; 2013 Aug; 101 Suppl 1():S45-9. PubMed ID: 23958572 [TBL] [Abstract][Full Text] [Related]
19. Individualised treatment targets in patients with type-2 diabetes and hypertension. Schmieder RE; Tschöpe D; Koch C; Ouarrak T; Gitt AK; Cardiovasc Diabetol; 2018 Jan; 17(1):18. PubMed ID: 29357854 [TBL] [Abstract][Full Text] [Related]
20. Benefits and harms of intensive glycemic control in patients with type 2 diabetes. Rodriguez-Gutierrez R; Gonzalez-Gonzalez JG; Zuñiga-Hernandez JA; McCoy RG BMJ; 2019 Nov; 367():l5887. PubMed ID: 31690574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]